New in-house flow cytometry service
October 8, 2025

We are thrilled to announce that Pharmidex now offers an in-house flow cytometry service powered by the Attune™ NxT Acoustic Flow Cytometer + CytKick Max Autosampler, combining precision, throughput and cutting-edge capability.

With this platform, we can deliver a wide array of flow cytometry assays:


• High-dimensional immunophenotyping (T cells, B cells, NK, myeloid, ILCs)
• Viability/apoptosis, mitochondrial health, ROS and cell cycle analyses
• Functional assays: cytokine staining, proliferation, degranulation
• High-throughput screening (96/384-well plates) for drug candidates
• Rare-event detection (CTCs, minimal residual disease)
• Kinetic assays (calcium flux, uptake, time-course studies)


Pharmidex will integrate this new capability with our existing services:


• Histology & imaging: correlate cell subsets with tissue architecture
• Biomarker analysis: cross-validate flow-based biomarker readouts with proteomics, ELISA and transcriptomics
• In vivo & disease models: combine flow readouts from tissues/fluids with in vivo pharmacology, toxicology and PK/PD
• Autoimmune & immuno-oncology studies: dissect immune cell phenotypes, function and kinetics in preclinical models


If you’re interested in using flow cytometry in your next study or discussing how it can enhance your current project with Pharmidex’s broader service portfolio, I’d love to hear from you.

🔗 Learn more about our full services: (https://lnkd.in/eAdhrhFp) (https://lnkd.in/e9uXhXiB)

Flow Cytometry
Flow Cytometry
Flow Cytometry

#FlowCytometry #AttuneNxT #DrugDiscovery #Pharmidex #Immunology

The Pharmidex will be in London for London Life Sciences Week

November 19, 2025
The Pharmidex team will be in London for London Life Sciences Week from the 16th. Janette Dalay Robertson and Ash Alavijeh will be attending a range of events across the week. We are looking forward to a busy week discussing all things life-science related. Get in touch if you’d like to meet with us during the week as we visit existing clients and stakeholders!

Pharmidex will be attending the BMCS “New Approaches to the Treatment of Parkinson’s” meeting.

November 12, 2025
Our Head of Integrated Therapeutics and CNS, Dr. Stephen Mitchell , our Business Development Manager, Janette Dalay Robertson and our Senior Research Scientist in CNS, Jewel Ahmed will be there to engage with attendees, share insights and explore new collaborations driving innovation in Parkinson’s disease drug discovery and development. If you’re attending, don’t hesitate to reach out, they’ll be delighted to connect and discuss how Pharmidex’s integrated expertise can help move your research from concept to clinic.

OBN BioTuesday: Latest R&D for the Diagnosis of Prostate Cancer

November 11, 2025
We are delighted to share that Prof. Mo Alavijeh will be attending the upcoming 🔬 OBN (UK) Ltd BioTuesday: A Spotlight on the Latest R&D for the Diagnosis & Treatment of Prostate Cancer 📅 11 November 2025 📍 Ipsen, Paddington, London This event brings together leading experts and innovators shaping the future of prostate cancer research and therapy. If you’re attending, don’t miss the opportunity to meet with Prof. Mo Alavijeh (FRSC, FRSM), and explore how collaboration can accelerate progress in drug discovery and development.
More Posts